EUVIMEDEUVIMED entdecken
EditorialKommentarOpen Access

Toward More Equitable Breast Cancer Outcomes

Joann G Elmore, Christoph I Lee

JAMA · 2024

DOI: 10.1001/jama.2024.6052 ↗

Kurz gefasst

Editorial in der Zeitschrift JAMA, 2024. Verfasst von Joann G Elmore und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, UCLA National Clinician Scholar Program, David Geffen School of Medicine at UCLA, Los Angeles, California. Hauptthemen laut MEDLINE: Breast Neoplasms, Healthcare Disparities, Health Equity, Mammography. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In its revised Recommendation Statement, 1 the US Preventive Services Task Force (USPSTF) now recommends that all women undergo routine breast cancer screening every other year beginning at age 40 years.This is an adjustment from the 2016 recommendation for all women to start at age 50 and for women aged 40 to 49 to engage in individualized decision-making and part of an overarching aim to increase earlier detection of breast cancer and address inequalities in breast cancer mortality, especially among Black women. 1 Additionally, the task force, in acknowledgment of evolving technology, updated the recommended primary screening modalities to include digital breast tomosynthesis (3D mammography).They noted that digital breast tomosynthesis improves the benefit-to-risk ratio compared with digital mammography, primarily by decreasing false-positive results, a well-known screening-related harm. 2 The revised recommendations from the USPSTF shed light on 2 major issues that demand greater attention: addressing health inequities related to breast cancer outcomes and ensuring benefits for all women amid rapid screening technological advancements.The major impetus for lowering the recommended start age to 40 years stems from the observed increase in breast cancer incidence noted among women in their 40s and the need to tackle disparities affecting specific subpopulations.Notably, Black women continue to face disproportionately high mortality rates, 40% higher compared with White women in the US. 3 Black women also experience more aggressive cancer subtypes, such as triple-negative cancers, and tend to have cancers diagnosed at later stages, compared with White women.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHealthcare DisparitiesHealth EquityMammographyFemaleHumansUnited StatesMass ScreeningAdultMiddle AgedBlack or African AmericanWhiteComputer SimulationHispanic or LatinoBiopsy

Autor:innen und Institutionen

  • Department of Medicine, UCLA National Clinician Scholar Program, David Geffen School of Medicine at UCLA, Los Angeles, California.
  • Department of Radiology, University of Washington School of Medicine.
  • Department of Health Systems and Population Health, University of Washington School of Public Health, Seattle.
  • Fred Hutchinson Cancer Center, Seattle, Washington.

Förderung

  • NCI NIH HHS

Zitieren

APA

Elmore, J. G., & Lee, C. I. (2024). Toward More Equitable Breast Cancer Outcomes. JAMA. https://doi.org/10.1001/jama.2024.6052

Vancouver

Elmore JG, Lee CI. Toward More Equitable Breast Cancer Outcomes. JAMA. 2024. doi:10.1001/jama.2024.6052

BibTeX
@article{Elmore2024,
  author = {Elmore, Joann G and Lee, Christoph I},
  title = {Toward More Equitable Breast Cancer Outcomes},
  journal = {JAMA},
  year = {2024},
  doi = {10.1001/jama.2024.6052}
}
Kostenlos starten →